Intravenous Levodopa ( DrugBank: Levodopa )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
6	パーキンソン病	4

6. パーキンソン病

臨床試験数 : 2,307 / 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

diseases per page:

Showing 1 to 4 of 4 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00605553 (ClinicalTrials.gov)	April 2008	15/1/2008	Study to Evaluate SYN115 in Parkinson's Disease	A Randomized, Double-blind, Placebo Controlled, Two-way Cross-over Study to Explore the Effects of 7 ...	Parkinson's Disease	Drug: Placebo;Drug: Tozadenant	Biotie Therapies Inc.	NULL	Completed	40 Years	75 Years	All	30	Phase 2	United States
2	NCT00089622 (ClinicalTrials.gov)	August 4, 2004	6/8/2004	Lisuride Patch to Treat Parkinson's Disease	Transcutaneous Lisuride Therapy of Parkinson's Disease	Parkinson Disease	Drug: Intravenous Levodopa;Drug: Lisuride Transdermal System	National Institute of Neurological Disorders and Stroke (NINDS)	NULL	Completed	40 Years	80 Years	All	40	Phase 2	United States
3	NCT00086294 (ClinicalTrials.gov)	June 25, 2004	29/6/2004	ACP-103 to Treat Parkinson's Disease	5HT2A/C Serotonin Blockade in Parkinson's Disease	Parkinson's Disease;Dyskinesias	Drug: Intravenous Levodopa;Drug: ACP-103	National Institute of Neurological Disorders and Stroke (NINDS)	NULL	Completed	30 Years	80 Years	All	40	Phase 2	United States
4	NCT00076674 (ClinicalTrials.gov)	January 2004	28/1/2004	Levetiracetam Treatment of L-dopa Induced Dyskinesias	Levetiracetam Treatment of L-dopa Induced Dyskinesias	Dyskinesias;Parkinson Disease	Drug: Intravenous Levodopa	National Institute of Neurological Disorders and Stroke (NINDS)	NULL	Completed	N/A	N/A	Both	40	Phase 2	United States

First Previous1Next Last